Insiders Buying Joint Corp And 2 Other Stocks
Portfolio Pulse from Lisa Levin
Insiders at Joint Corp (JYNT), Nuvectis Pharma (NVCT), and Byrna Technologies (BYRN) have recently made notable stock purchases. Jefferson Gramm, 10% owner of Joint Corp, acquired 22,463 shares at an average price of $13.03. Ron Bentsur, CEO and Chairman of Nuvectis Pharma, bought 260 shares at an average price of $15.52. Luan Pham, Chief Marketing and Revenue Officer at Byrna Technologies, purchased 5,508 shares at an average price of $3.73.
July 19, 2023 | 1:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Luan Pham, Chief Marketing and Revenue Officer at Byrna Technologies, purchased 5,508 shares at an average price of $3.73.
Insider buying often signals confidence in a company's prospects. The purchase by the Chief Marketing and Revenue Officer could indicate a positive outlook for Byrna Technologies.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Jefferson Gramm, 10% owner of Joint Corp, acquired 22,463 shares at an average price of $13.03.
Insider buying often signals confidence in a company's prospects. The purchase by a 10% owner could indicate a positive outlook for Joint Corp.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Ron Bentsur, CEO and Chairman of Nuvectis Pharma, bought 260 shares at an average price of $15.52.
Insider buying often signals confidence in a company's prospects. The purchase by the CEO and Chairman could indicate a positive outlook for Nuvectis Pharma.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100